How can we best reduce the risk of severe adverse reactions to marketed drugs? An international group of scientists argues that a global research network is needed to identify genetically at-risk populations.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multi-view feature representation and fusion for drug-drug interactions prediction
BMC Bioinformatics Open Access 14 March 2023
-
DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology
Journal of Cheminformatics Open Access 12 November 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Institute of Medicine report The Future of Drug Safetyhttp://www.iom.edu/CMS/3793/26341/37329.aspx
Lazarou, J., Pomeranz, B. H. & Corey, P. N. J. Am. Med. Assoc. 279, 1200–1205 (1998).
van der Hooft, C. S. et al. Drug Saf. 29, 161–168 (2006).
Huang, S. M. et al. Toxicol. Mech. Meth. 16, 89–99 (2006).
Beutler, E. Pharmacol. Rev. 21, 73–103 (1969).
Roden, D. M. et al. Ann. Intern. Med. 145, 749–757 (2006).
Hazell, L. & Shakir, S. A. Drug Saf. 29, 385–396 (2006).
Molokhia, M. & McKeigue, P. Pharmacogenomics 7, 633–638 (2006).
Johnson, T. N. Toxicology 192, 37–48 (2003).
Eichelbaum, M., Ingelman-Sundberg, M. & Evans, W. E. Annu. Rev. Med. 57, 119–137 (2006).
Roden, D. M. N. Engl. J. Med. 350, 1013–1022 (2004).
Watkins, P. B. & Seeff, L. B. Hepatology 43, 618–631 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giacomini, K., Krauss, R., Roden, D. et al. When good drugs go bad. Nature 446, 975–977 (2007). https://doi.org/10.1038/446975a
Published:
Issue Date:
DOI: https://doi.org/10.1038/446975a
This article is cited by
-
Multi-view feature representation and fusion for drug-drug interactions prediction
BMC Bioinformatics (2023)
-
MS-ADR: predicting drug–drug adverse reactions base on multi-source heterogeneous convolutional signed network
Soft Computing (2022)
-
Synthesis, characterization and kinetics of sustained pantoprazole release studies of interpenetrated poly(acrylic acid)-chitosan-bentonite hydrogels for drug delivery systems
Reaction Kinetics, Mechanisms and Catalysis (2022)
-
Evaluation of genetic instability, oxidative stress, and metabolism-related gene polymorphisms in workers exposed to waste anesthetic gases
Environmental Science and Pollution Research (2022)
-
Indexing important drugs from medical literature
Scientometrics (2022)